|
1
|
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
|
Ann Oncol
|
2010
|
2.49
|
|
2
|
The role of pemetrexed in advanced non small-cell lung cancer: special focus on pharmacology and mechanism of action.
|
Curr Drug Targets
|
2010
|
1.03
|
|
3
|
1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer.
|
Ann Oncol
|
2011
|
0.82
|
|
4
|
Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis.
|
Ann Oncol
|
2010
|
0.81
|
|
5
|
Activity of pemetrexed against brain metastases in a patient with adenocarcinoma of the lung.
|
Lung Cancer
|
2009
|
0.79
|
|
6
|
Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer.
|
Eur Respir J
|
2011
|
0.78
|